Product Information
METHIMAZOLE 10 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.1171 per EA under NDC 00832607311. Its NADAC has been published 118 times since Jul 3, 2024.
FDA first approved this application on Feb 18, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832607311
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040547FDA Approved
2/18/2005
TE Code
AB
On Market Since
7/1/2016
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 10 MG TABLET has been published 118 times since Jul 3, 2024, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1171 per EA |
|---|---|
| All-time high | $0.1618 (Jul 10, 2024) |
| All-time low | $0.1062 (Nov 20, 2024) |
| 52-week high | $0.1339 |
| 52-week low | $0.1163 |
| Median price | $0.1247 |
| Average price | $0.1251 |
| Largest weekly change | -20.5% (Jul 17, 2024) |
| Weeks tracked | 118 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methimazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thyroid Hormone Synthesis Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHIMAZOLE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 10 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1171 per EA (NDC 00832607311), effective Sep 30, 2026.
How has the price of METHIMAZOLE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 10 MG TABLET has declined 27.7%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 10 MG TABLET?
Since Jul 3, 2024, the NADAC for METHIMAZOLE 10 MG TABLET has ranged from a low of $0.1062 (Nov 20, 2024) to a high of $0.1618 (Jul 10, 2024), with a median of $0.1247 per EA.
Are there cheaper alternatives to METHIMAZOLE 10 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHIMAZOLE 10 MG TABLET?
METHIMAZOLE 10 MG TABLET (NDC 00832607311) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.